Boothbay Fund Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-21,582
Closed -$322K 2179
2023
Q3
$322K Buy
+21,582
New +$286K 0.01% 1221
2023
Q2
Sell
-16,249
Closed -$142K 2554
2023
Q1
$142K Sell
16,249
-1,822
-10% -$14.6K ﹤0.01% 1839
2022
Q4
$113K Buy
+18,071
New +$68.7K ﹤0.01% 1753
2022
Q3
Sell
-14,479
Closed -$43K 2784
2022
Q2
$43K Buy
+14,479
New +$34.6K ﹤0.01% 2087
2020
Q3
Sell
-159,465
Closed -$557K 1348
2020
Q2
$557K Sell
159,465
-54,971
-26% -$159K 0.05% 549
2020
Q1
$317K Buy
+214,436
New +$360K 0.03% 558
2019
Q4
Sell
-26,790
Closed -$137K 1101
2019
Q3
$137K Buy
+26,790
New +$162K 0.02% 684
2017
Q4
Sell
-50,077
Closed -$404K 883
2017
Q3
$404K Buy
+50,077
New +$339K 0.08% 306
2015
Q4
Sell
-21,897
Closed -$42K 700
2015
Q3
$42K Buy
+21,897
New +$59.6K 0.03% 431

Other funds holding CBAY